| Rus |  |
Eng |  |
Congratulations to Professor Yury Gogotsi with being elected as a Fellow of the European Academy of Sciences!
In January 2019 professor Yury Gogotsi was elected as a Fellow of the European Academy of Sciences (EURASC) - a non-profit non-governmental, independent organization of the most distinguished scholars and engineers performing forefront research and the development of advanced technologies, united by a commitment to promoting science and technology and their essential roles in fostering social and economic development.
Professor Yury Gogotsi is a leading Ukrainian and American scientist in the field of material chemistry, professor at Drexel University, Philadelphia, PA since the year 2000 in the fields of Materials Science and Engineering and Nanotechnology. Professor Yury Gogotsi is Distinguished University Professor and Trustee Chair in the Department of Materials Science and Engineering at Drexel University. He also holds courtesy appointments in the Departments of Chemistry and Mechanical Engineering and Mechanics at Drexel University, and serves as Director of the A.J. Drexel Nanotechnology Institute. He served as Associate Dean of the College of Engineering from 2003 to 2007. He received his MS (1984) and PhD (1986) degrees from Kiev Polytechnic and a DSc degree from the Ukrainian Academy of Sciences in 1995.
He is the founding Director of the A.J. Drexel Nanomaterials Institute and Associate Editor of ACS Nano. He works on nanostructured carbons and two-dimensional carbides for energy related and biomedical applications. His work on selective extraction synthesis of carbon and carbide nanomaterials with tuneable structure and porosity had a strong impact on the field of capacitive energy storage. He has co-authored 2 books, more than 500 journal papers and obtained more than 50 patents. He has received numerous national and international awards for his research. He was recognized as Highly Cited Researcher by Thomson-Reuters in 2014-2018, and elected a Fellow of AAAS, MRS, ECS, RSC, ACerS, NANOSMAT Society and a member of the World Academy of Ceramics. He also serves on the MRS Board of Directors.
Read more about EURASC at www.eurasc.org
MXenes potential applications include sensors, wound healing materials, and drug delivery systems. A recent study explored how different synthesis methods affect the safety and performance of MXenes. By comparing etching conditions and intercalation strategies, researchers discovered that fine-tuning the surface chemistry of MXenes plays a crucial role in improving biocompatibility. These results provide practical guidelines for developing safer MXenes and bring the field one step closer to real biomedical applications.
Exellent news, our joint patent application with Drexel University on highly porous MAX phase precursor for MXene synthesis published. Congratulations and thanks to all team involved!
Last Call! Have you submitted your abstract for IEEE NAP-2025 yet? Join us at the International Symposium on "The MXene Frontier: Transformative Nanomaterials Shaping the Future" – the largest MXene-focused conference in Europe this year! Final Submission Deadline: May 15, 2025. Don’t miss this exclusive opportunity to showcase your research and engage with world leaders in the MXene field!
We are excited to announce the publication of latest review article on MXenes in Healthcare. This comprehensive review explores the groundbreaking role of MXenes—an emerging class of 2D materials—in revolutionizing the fields of medical diagnostics and therapeutics. Read the full article here: https://doi.org/10.1039/D4NR04853A.
Congratulations and thank you to our collaborators from TU Wien and CEST for very interesting work and making it published! In this work, an upscalable electrochemical MXene synthesis is presented. Yields of up to 60% electrochemical MXene (EC-MXene) with no byproducts from a single exfoliation cycle are achieved.
Congratulations to all collaborators with this interesting joint work!
Thank you to our collaborators for the amazing joint work recently published in Graphene and 2D Nanomaterials about MXene–silk fibroin composite films aiming to develop materials with tunable electronic and thermal properties
Dr. Oleksiy Gogotsi, director of MRC and Carbon-Ukraine, innovative companies that are among the leaders on the world MXene market, visited 2024 MRS Fall Meeting & Exhibit. together with Dr. Maksym Pogorielov, Head of Advanced Biomaterials and Biophysics Laboratory, University of Latvia.
MRC and Carbon-Ukraine team visited the 3rd International MXene conference held at Drexel University on August 5-8, 2024. Conference brought together the best reserchers and leading experts on MXene field. 
Together with colleagues from the University of Latvia, MRC/Carbone Ukraine, Adam Mickiewicz University, University Clinic Essen, and others, we have developed a novel concept involving the binding of antibodies to MXenes. In our research, we utilized anti-CEACAM1 antibodies to develop targeted photo-thermal therapy for melanoma (in vitro), paving the way for future in vivo studies and clinical trials. For the first time, we demonstrate the feasibility of delivering MXenes specifically targeted to melanoma cells, enabling the effective ablation of cancer cells under near-infrared (NIR) light. This new technique opens up vast potential for the application of MXenes in cancer treatment, diagnostics, drug delivery, and many other medical purposes.
